Hjem › Brystkreft › Colorado › Aurora
Kliniske studier for Brystkreft i Aurora, CO
28 studier for Brystkreft søker deltakere på steder i og rundt Aurora (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RekruttererFase 1
- University of Colorado, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RekruttererFase 1/2
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruttererFase 2
- University of Colorado School of Medicine, Aurora
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruttererFase 3
- University of Colorado Anschutz Medical Campus ( Site 0061), Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Aurora
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- University of Colorado Anschutz Medical Campus, Aurora
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruttererFase 3
- Clinical Trial Site, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- University of Colorado Cancer Center, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
RekruttererFase 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- UCHealth University of Colorado Hospital, Aurora
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruttererFase 2
- University Of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruttererFase 2/3
- Local Institution - 0289, Aurora
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- UCHealth University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- University of Colorado Cancer Center, Aurora
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
RekruttererFase 1/2
- University of Colorado Anschutz Medical Campus ( Site 0057), Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- University of Colorado Cancer Center, Aurora
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Rocky Mountain Cancer Centers LLP, Aurora
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Rocky Mountain Cancer Centers-Aurora, Aurora
Improving Care for Rural Patients With Solid Tumors
Rekrutterer
- University of Colorado Hospital, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
RekruttererFase 2
- University of Colorado Anschutz Medical Campus, Aurora
The Immune System's Response to Young Women's Breast Cancer
RekruttererObservasjonsstudie
- University of Colorado Denver, Aurora
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruttererObservasjonsstudie
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Aurora
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- Rocky Mountain Cancer Centers, Aurora
- University of Colorado Cancer Center, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruttererObservasjonsstudie
- University of Colorado Cancer Center, Aurora
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
RekruttererFase 3
- Rocky Mountain Cancer Centers - Aurora, Aurora
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Aurora
- Kreft (alle typer)35 studier
- Kolorektal kreft32 studier
- Ikke-småcellet lungekreft31 studier
- Eggstokkreft25 studier
- Metastatisk kreft25 studier
- Type 1-diabetes23 studier
- Fedme22 studier
- Prostatakreft19 studier
- Lungekreft19 studier
- Hjertesvikt18 studier
- Melanom18 studier
- Akut myelogen leukemi16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.